Clidinium Bromide: A Pharmaceutical Intermediate with Anticholinergic Properties

Discover the critical role of Clidinium Bromide (CAS 3485-62-9) as a key pharmaceutical raw material.

Get a Quote & Sample

Advantages Offered

High Purity for Pharmaceutical Use

With a purity of 97% minimum, Clidinium Bromide meets the stringent requirements for pharmaceutical applications, ensuring the efficacy and safety of the final drug products.

Versatile Application in Drug Formulation

Its role as a pharmaceutical intermediate makes it a versatile building block for a range of therapeutic agents, particularly those targeting the digestive system.

Established Chemical Identity

The well-defined chemical properties and CAS number (3485-62-9) of Clidinium Bromide facilitate seamless integration into existing pharmaceutical synthesis and quality control protocols.

Key Applications

Gastrointestinal Disorder Treatment

Clidinium Bromide is instrumental in creating antispasmodic medications used to alleviate symptoms of Irritable Bowel Syndrome (IBS) and peptic ulcers.

API Synthesis

As a crucial intermediate, it is fundamental in the multi-step synthesis of various Active Pharmaceutical Ingredients (APIs).

Drug Development

Its unique chemical structure and properties make it a valuable compound for ongoing research and development in novel pharmaceutical therapies.

Chemical Manufacturing

Essential for manufacturers producing high-quality pharmaceutical raw materials for the global market.